All Stories

  1. Computer-aided Design of Coumarins for Neurodegenerative Diseases: Trends of the Last Decade
  2. Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists
  3. Artificial Intelligence Applied to Flavonoid Data in Food Matrices
  4. Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins
  5. Enhancement of the Anti-Aggregation Activity of a Molecular Chaperone Using a Rationally Designed Post-Translational Modification
  6. Design, Synthesis and Docking Calculations of Prenylated Chalcones as Selective Monoamine Oxidase B Inhibitors with Antioxidant Activity
  7. Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation
  8. Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives
  9. Targeting α -(1,4)-Glucosidase in Diabetes Mellitus Type 2: The Role of New Synthetic Coumarins as Potent Inhibitors
  10. Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease
  11. Coumarin derivatives as promising xanthine oxidase inhibitors
  12. Efficient and irreversible antibody–cysteine bioconjugation using carbonylacrylic reagents
  13. PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor
  14. Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates
  15. Unexpected one-step synthesis of 3-benzoyl-2-phenylbenzofurans under Wittig conditions
  16. A silicon-labelled amino acid suitable for late-stage fluorination and unexpected oxidative cleavage reactions in the preparation of a key intermediate in the Strecker synthesis
  17. Evaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarins
  18. Learning from nature: the role of albumin in drug delivery
  19. Trends in patented chromones for skin diseases
  20. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
  21. Chemo- and Regioselective Lysine Modification on Native Proteins
  22. Coumarins as Promising Scaffold for the Treatment of Age-related Diseases – An Overview of the Last Five Years
  23. A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging
  24. Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation
  25. Coumarins and adenosine receptors: New perceptions in structure-affinity relationships
  26. Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
  27. New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies
  28. Heterocyclic Antioxidants in Nature: Coumarins
  29. Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins
  30. In silico genotoxicity of coumarins: application of the Phenol-Explorer food database to functional food science
  31. MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, in vitro study, and docking calculations
  32. Trends in therapeutic drug conjugates for bacterial diseases: a patent review
  33. Structural elucidation of a series of 6-methyl-3-carboxamidocoumarins
  34. In silico study of new structural alerts of agents clastogenic
  35. Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents
  36. Evaluation of Antioxidant and Antitrypanosomal Properties of a Selected Series of Synthetic 3-Carboxamidocoumarins
  37. Facing Chagas' Disease: Trypanocidal Properties of New Coumarinchalcone Scaffolds
  38. 6-Methyl-2-oxo-N-(quinolin-6-yl)-2H-chromene-3-carboxamide: crystal structure and Hirshfeld surface analysis
  39. Crystal structures of three 6-substituted coumarin-3-carboxamide derivatives
  40. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling
  41. Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold
  42. Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core
  43. Prediction of the total antioxidant capacity of food based on artificial intelligence algorithms
  44. Design, synthesis and antibacterial study of new potent and selective coumarin–chalcone derivatives for the treatment of tenacibaculosis
  45. 3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases
  46. Coumarins — An Important Class of Phytochemicals
  47. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold
  48. Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties
  49. In silico clastogenic activity of dietary phenolic acids
  50. Interest of Antioxidant Agents in Parasitic Diseases. The Case Study of Coumarins
  51. Oxidative Stress and Neurodegenerative Diseases: Looking for a Therapeutic Solution Inspired on Benzopyran Chemistry
  52. Study of Coumarin-Resveratrol Hybrids as Potent Antioxidant Compounds
  53. Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives
  54. Potential pharmacological uses of chalcones: a patent review (from June 2011 – 2014)
  55. Design and discovery of tyrosinase inhibitors based on a coumarin scaffold
  56. Back Cover: Insight into the Interactions between Novel Coumarin Derivatives and Human A3 Adenosine Receptors (ChemMedChem 10/2014)
  57. Insight into the Interactions between Novel Coumarin Derivatives and Human A3 Adenosine Receptors
  58. Synthesis and electrochemical study of new 3-(hydroxyphenyl)benzo[f]coumarins
  59. Insight into the Functional and Structural Properties of 3‐Arylcoumarin as an Interesting Scaffold in Monoamine Oxidase B Inhibition
  60. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases
  61. Chromone: A Valid Scaffold in Medicinal Chemistry
  62. Synthesis and evaluation of antioxidant and trypanocidal properties of a selected series of coumarin derivatives
  63. Comparative study of the 3-phenylcoumarin scaffold: Synthesis, X-ray structural analysis and semiempirical calculations of a selected series of compounds
  64. Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins
  65. QSAR and Complex Network Recognition of miRNAs in Stem Cells
  66. Synthesis and Electrochemical and Biological Studies of Novel Coumarin–Chalcone Hybrid Compounds
  67. Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins
  68. Synthesis, NMR characterization, X-ray structural analysis and theoretical calculations of amide and ester derivatives of the coumarin scaffold
  69. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study
  70. (1S,2S,5S)-2-Methyl-3-oxo-5-(prop-1-en-2-yl)cyclohexane-1-carbonitrile
  71. [(2S,3aR,6aR)-5-Oxohexahydrofuro[3,2-b]furan-2-yl]methyl acetate
  72. MAO Inhibitory Activity of 2‐Arylbenzofurans versus 3‐Arylcoumarins: Synthesis, in vitro Study, and Docking Calculations
  73. ChemInform Abstract: Improved Synthesis of 3‐(Aminoaryl)coumarins.
  74. Editorial (Hot Topic: Monoamine Oxidase as a Target in Medicinal Chemistry and Drug Discovery)
  75. Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins As An Interesting Scaffold
  76. Chalcone-based derivatives as new scaffolds for h A3 adenosine receptor antagonists
  77. Synthesis and Structure-Activity Relationships of Novel Amino/Nitro Substituted 3-Arylcoumarins as Antibacterial Agents
  78. Synthesis of coumarin–chalcone hybrids and evaluation of their antioxidant and trypanocidal properties
  79. New hydroxylated 3-arylcoumarins, synthesis and electrochemical study
  80. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives
  81. N-(2-Oxo-2H-chromen-3-yl)cyclohexanecarboxamide
  82. Looking for New Targets: Simple Coumarins as Antibacterial Agents
  83. Editorial (Hot Topic: Monoamine Oxidase as a Target in Medicinal Chemistry and Drug Discovery)
  84. Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins As An Interesting Scaffold
  85. Monoamine Oxidase Inhibitors: Ten Years of Docking Studies
  86. Looking for New Targets: Simple Coumarins as Antibacterial Agents
  87. Monoamino Oxidase A: An Interesting Pharmacological Target for the Development of Multi-Target QSAR
  88. Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance
  89. 3-Phenylcoumarin
  90. In search for new chemical entities as adenosine receptor ligands: Development of agents based on benzo-γ-pyrone skeleton
  91. Tyrosine-like condensed derivatives as tyrosinase inhibitors
  92. Structural Alerts for Predicting Clastogenic Activity of Pro-oxidant Flavonoid Compounds
  93. Thyroid carcinoma in children and adolescents: A retrospective review
  94. 8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies
  95. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease
  96. Improved Synthesis of 3-(Aminoaryl)coumarins
  97. Hydroxycoumarins as selective MAO-B inhibitors
  98. Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors
  99. ChemInform Abstract: New Halogenated Phenylcoumarins as Tyrosinase Inhibitors.
  100. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins
  101. New halogenated phenylcoumarins as tyrosinase inhibitors
  102. ChemInform Abstract: Synthesis of 3‐Arylcoumarins via Suzuki Cross‐Coupling Reactions of 3‐Chlorocoumarin.
  103. Synthesis of 3-arylcoumarins via Suzuki-cross-coupling reactions of 3-chlorocoumarin
  104. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors
  105. Regioselective Synthesis of Bromo-Substituted 3-Arylcoumarins
  106. ChemInform Abstract: A New Series of 3‐Phenylcoumarins as Potent and Selective MAO‐B Inhibitors.
  107. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors
  108. Tyrosinase Inhibitor Activity of Coumarin-Resveratrol Hybrids
  109. Synthesis of Regioisomeric Functionalized Benzodifurans and Angelicins
  110. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors